Results 71 to 80 of about 34,162 (209)
GLP‐1 receptor agonists and serious adverse events: Evidence, uncertainty and clinical implications
Abstract Glucagon‐like peptide‐1 (GLP‐1) receptor agonists provide benefits in weight reduction, glycaemic control in Type 2 diabetes, and cardiovascular and renal outcomes. Their widespread use has given rise to concerns regarding rare but potentially serious adverse events.
Peter Ueda
wiley +1 more source
BackgroundCardiovascular illness and gallstones are closely related. Our goal was to determine whether gallstones and the updated LE8 score, which measures cardiovascular health among US adults, are related.Methods3,570 adults participated in the 2017 ...
Ting Wang +3 more
doaj +1 more source
Management of gallstones and gallbladder disease in patients undergoing gastric bypass
The appropriate management of gallstones and gall-bladder disease in patients undergoing gastric bypass remains unknown. Several therapeutic modalities are used and include performing cholecystectomy on all patients at the time of gastric bypass ...
Gallstones Cholecystectomy +4 more
core
Analysis the bacterial community structure of human cholesterol gallstones by PCR-DGGE
In this study, the microbial community of cholesterol gallstones and bile were examined by polymerase chain reaction-denaturing gradient gel electrophoresis (DGGE). The DGGE results showed that there are 13 genera in cholesterol gallstones.
PENG Yu-Hong +7 more
doaj
BackgroundGallstones are the most prevalent cause of hospitalization among digestive disorders. For humans, sleep is an essential physiological function.
Jianwei Cao +5 more
doaj +1 more source
Abdominal Symptoms and Incident Gallstones in a Population Unaware of Gallstone Status
Introduction. Symptoms associated with newly formed gallstones have never been studied in a population unaware of their gallstones. The objective of this population-based cohort study was to determine which debut of abdominal symptoms was associated with
Daniel Mønsted Shabanzadeh +2 more
doaj +1 more source
Abdominal symptoms and food intolerance related to gallstones.
Department of Epidemiology and Academic Hospital Maastricht, Maastricht University, The Netherlands. We have evaluated the association between gallstones and abdominal symptoms, comparing two different study designs. We asked questions on abdominal pain,
Knipschild, P.G. +1 more
core +1 more source
Abstract figure legend During GLP‐1RA treatment reduced appetite and energy intake, delayed gastric emptying, decreased visceral fat mass and improved glycaemic control contribute to weight loss. After treatment cessation these benefits are partially or completely reversed, resulting in weight regain, accompanied by increased appetite and energy intake,
Camille E. M. Piguet +2 more
wiley +1 more source
Gallstones develop in approximately 10% to 15% of the US population and represent one of the most common and most costly of all digestive diseases. Studies investigating gallstones\u27 natural history have shown that gallstone-related complications arise
Wang, Jeffrey K +2 more
core +1 more source

